eptacog beta efficacy in children and adolescents with hemophilia a or b with inhibitors
Published 2 years ago • 103 plays • Length 3:00Download video MP4
Download video MP3
Similar videos
-
1:23
the safety and efficacy of eptacog beta in patients with hemophilia
-
4:57
a potential novel hemophilia treatment: an in vitro study of eptacog beta and emicizumab
-
1:23
the present and future of hemophilia a treatment
-
2:08
an overview of ongoing clinical trials for the treatment of hemophilia
-
4:43
novel treatments being explored for patients with hemophilia: highlights from isth 2024
-
1:08
a phase ii study of ruxolitinib with chemotherapy in pediatric patients with ph-like all
-
1:09
highlights from isth: gene therapy in hemophilia a & undiagnosed bleeding disorders in pediatrics
-
0:49
the future of pediatric clinical trials
-
3:17
thrombopoietin receptor agonists in itp: current status and future outlooks
-
1:35
outcomes of allosct following blinatumomab in children and young adults with r/r b-all
-
3:49
hope-b trial: etranacogene dezaparvovec shows promise in hemophilia b
-
8:38
treating transfusion dependent and independent beta-thalassemia, and believe/beyond trial updates
-
5:24
safety by treatment phase and age when treating flt3-itd-mutated aml with quizartinib and chemo
-
2:11
update on phase i/ii study of azacitidine, venetoclax and gilteritinib in patients with flt3 aml
-
1:37
the role of ctdna in hodgkin lymphoma
-
2:02
safety and efficacy of cd45ra -depleted dli in pediatric stem cell transplant recipients
-
0:44
the recent fda approval of ponatinib for ph all following success in the phallcon trial
-
1:03
insights into the cartitude-6 trial: rationale and design